Document is current
Any future updates will be listed below
-
Authors
Parent, Ephraim E.
Benayoun, Marc
Ibeanu, Ijeoma
Olson, Jeffrey J.
Hadjipanayis, Constantinos G.
Brat, Daniel J.
Adhikarla, Vikram
Nye, Jonathon
Schuster, David M.
Goodman, Mark M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 5RO1CA121320)
- License Information
-
More Information
Article History
Received: 5 April 2018
Accepted: 27 June 2018
First Online: 25 July 2018
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The recruitment protocol was approved by the Institutional Review Board (IRB) and complied with the Health Insurance Portability and Accountability Act (HIPPA). Informed consent was obtained from all individual participants included in the study.
: Informed consent was obtained from all individual participants included in the study.
: The authors have participated in sponsored research involving <sup>18</sup>F-fluciclovine, among other radiotracers. Emory University and Dr. Mark Goodman are eligible to receive royalties for <sup>18</sup>F-fluciclovine. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
